ESTIMATED
10/03/2023
10/03/2023
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.60 | -$0.60 | -$0.60 |
Q2 2024 | 1 | -$0.67 | -$0.67 | -$0.67 |
Q3 2024 | 0 | -$0.60 | -$0.60 | -$0.60 |
Q4 2024 | 0 | -$0.52 | -$0.52 | -$0.52 |
Q1 2025 | 0 | -$0.35 | -$0.35 | -$0.35 |
Q2 2025 | 0 | -$0.31 | -$0.31 | -$0.31 |
Q3 2025 | 0 | -$0.21 | -$0.21 | -$0.21 |
Q4 2025 | 0 | -$0.17 | -$0.17 | -$0.17 |
Trinity Biotech plc last posted its earnings results on Tuesday, October 3rd, 2023. The company reported $-1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.09 by $0.91. The company had revenue of 14.70 M for the quarter and had revenue of 56.83 M for the year. Trinity Biotech plc has generated $-3 earnings per share over the last year ($-2.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.88. Trinity Biotech plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 23rd, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/05/2024 | Q1 2024 | -$0.37 | $16.00 M | $14.70 M | 04/30/2024 | Q4 2023 | -$0.72 | $15.00 M | $13.43 M | 10/06/2023 | Q3 2023 | -$0.88 | $14.50 M | $14.68 M | 07/10/2023 | Q2 2023 | -$0.78 | $13.50 M | $13.90 M | 03/27/2023 | Q1 2023 | -$0.83 | $18.50 M | $14.83 M | 12/16/2022 | Q4 2022 | -$1.32 | $18.00 M | $18.04 M | 09/06/2023 | Q3 2022 | -$1.17 | $19.50 M | $19.50 M | 07/01/2022 | Q2 2022 | -$0.59 | $18.75 M | $18.46 M | 04/11/2022 | Q1 2022 | $0.07 | -$0.08 | -0.15 | $18.78 M | 05/02/2022 | Q4 2021 | $0.40 | $19.53 M | 09/30/2021 | Q3 2021 | $0.06 | $24.25 M | $22.00 M | 06/30/2021 | Q2 2021 | -$0.19 | $24.00 M | $25.84 M | 03/31/2021 | Q1 2021 | $0.08 | $25.59 M | 04/30/2021 | Q4 2020 | -$2.40 | $32.77 M | 09/30/2020 | Q3 2020 | $0.35 | $28.00 M | $32.01 M | 06/30/2020 | Q2 2020 | -$0.35 | $13.00 M | $16.02 M | 03/31/2020 | Q1 2020 | -$0.53 | $21.18 M | 06/15/2020 | Q4 2019 | -$5.58 | $21.32 M | 09/30/2019 | Q3 2019 | $0.00 | $24.50 M | $24.59 M | 06/30/2019 | Q2 2019 | -$1.29 | $24.00 M | $22.50 M |
---|
A. Trinity Biotech plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 23rd, 2024 based off last year's report dates.
A. The conference call for Trinity Biotech plc's latest earnings report can be listened to online.
A. The conference call transcript for Trinity Biotech plc's latest earnings report can be read online.
A. Trinity Biotech plc (NASDAQ:TRIB) has a recorded annual revenue of $56.83 M.
A. Trinity Biotech plc (NASDAQ:TRIB) has a recorded net income of $56.83 M. Trinity Biotech plc has generated $-3.14 earnings per share over the last four quarters.
A. Trinity Biotech plc (NASDAQ:TRIB) has a price-to-earnings ratio of -0.88 and price/earnings-to-growth ratio is -0.02.